Medical Oncology

, 31:943 | Cite as

Risk of colorectal cancer among long-term cervical cancer survivors

  • Ana M. Rodriguez
  • Yong-Fang Kuo
  • James S. Goodwin
Original Paper


Because advances in therapy have increased long-term survival for women with cervical cancer, it is important to study the risk of secondary primary malignancies in high-dose organ areas. From the 1973–2009 National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, we studied the risk of developing cancer of the colon and rectum in 64,507 cervical cancer patients over 35 years after initial radiation treatment. We also assessed change in risk over time. Kaplan–Meier estimator for survival curve and Cox proportional hazards models was used. More than half (52.6 %) of the cervical cancer patients received radiation treatment. In the analyses adjusted for race/ethnicity, age, marital status, surgery status, stage and grade, the risk of colon cancer between those both with and without XRT diverged beginning at approximately 8 years. After 8 years, the hazard ratio for developing colon cancer was 2.00 (95 % CI 1.43–2.80) for women with radiation versus those without radiation treatment. The risk of rectal cancer diverged after 15 years of follow-up (HR 4.04, 95 % CI 2.08–7.86). After 35 years of follow-up, the absolute risk of developing colon cancer was 6.5 % for those who received radiation versus 2.5 % for those without, and 3.7 versus 0.8 % for rectum. The risk of colon and rectum cancer over 20 years of follow-up after radiation remained the same across three eras (1973–1980, 1981–1990, and 1991–2000). Radiation-induced second cancers of the colon and rectum may occur 8 years after radiation treatment for cervical cancer.


Cervical cancer SEER Second primary cancer Radiotherapy Colon cancer Rectal cancer 


  1. 1.
    Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Trends in Aged-Adjusted U.S. Mortality Rates by Cancer Site, All Ages, All Races, Female, 1975–2010.
  3. 3.
    de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev. 2013;22(4):561–70.CrossRefGoogle Scholar
  4. 4.
    Maher EJ, Denton A. Survivorship, late effects and cancer of the cervix. Clin Oncol (R Coll Radiol). 2008;20(6):479–87.CrossRefGoogle Scholar
  5. 5.
    Elena JW, Travis LB, Simonds NI, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst. 2013;105(2):85–94.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Kleinerman RA, Boice JD Jr, Storm HH, et al. Second primary cancer after treatment for cervical cancer: an international cancer registries study. Cancer. 1995;76(3):442–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009;91(1):4–15 discussion 11–13.CrossRefGoogle Scholar
  8. 8.
    Howlader NNA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013) (eds) SEER cancer statistics review, 1975–2010. 15 Jan 2014.
  9. 9.
    Stovall M, Smith SA, Rosenstein M. Tissue doses from radiotherapy of cancer of the uterine cervix. Med Phys. 1989;16(5):726–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Marcial VA, Marcial LV. Radiation therapy of cervical cancer: new developments. Cancer. 1993;71(4 Suppl):1438–45.PubMedGoogle Scholar
  11. 11.
    Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007;99(21):1634–43.PubMedCrossRefGoogle Scholar
  12. 12.
    Chaturvedi AK, Kleinerman RA, Hildesheim A, et al. Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol. 2009;27(6):967–73.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Berrington de Gonzalez A, Curtis RE, Kry SF, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 2011;12(4):353–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Oeffinger KC, Baxi SS, Novetsky Friedman D, Moskowitz CS. Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol. 2013;40(6):676–89.PubMedCrossRefGoogle Scholar
  15. 15.
    Overview of the SEER Program. 14 June 2013.
  16. 16.
    Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97(6):419–24.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. 2nd ed. New York: Springer; 2003.Google Scholar
  18. 18.
    Boice JD Jr, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res. 1988;116(1):3–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000;88(2):398–406.PubMedCrossRefGoogle Scholar
  20. 20.
    Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the third national cancer survey. J Natl Cancer Inst. 1977;58(3):525–47.PubMedGoogle Scholar
  21. 21.
    Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008;121(6):501–8 e503.PubMedCrossRefGoogle Scholar
  22. 22.
    Terry PD, Rohan TE, Franceschi S, Weiderpass E. Cigarette smoking and the risk of endometrial cancer. Lancet Oncol. 2002;3(8):470–80.PubMedCrossRefGoogle Scholar
  23. 23.
    Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med. 1986;315(21):1305–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Hoffmeister M, Jansen L, Stock C, Chang-Claude J, Brenner H. Smoking, lower gastrointestinal endoscopy, and risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(3):525–33.Google Scholar
  25. 25.
    Hoffmeister M, Schmitz S, Karmrodt E, et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol. 2010;8(10):870–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ana M. Rodriguez
    • 1
  • Yong-Fang Kuo
    • 2
  • James S. Goodwin
    • 2
  1. 1.Department of Obstetrics and GynecologyThe University of Texas Medical BranchGalvestonUSA
  2. 2.Department of Internal Medicine, Sealy Center on AgingThe University of Texas Medical Branch at GalvestonGalvestonUSA

Personalised recommendations